Phreesia (PHR) to Release Quarterly Earnings on Wednesday

Phreesia (NYSE:PHR – Get Rating) will be announcing its earnings results after the market closes on Wednesday, March 22nd. Analysts expect the company to announce earnings of ($0.78) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Phreesia Trading Up 4.0 %

Shares of PHR stock opened at $34.78 on Wednesday. The firm has a 50 day moving average price of $35.95 and a two-hundred day moving average price of $30.10. The company has a quick ratio of 3.94, a current ratio of 3.94 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $1.83 billion, a PE ratio of -9.82 and a beta of 0.65. Phreesia has a 12-month low of $13.19 and a 12-month high of $40.00.

Analyst Upgrades and Downgrades

PHR has been the subject of a number of analyst reports. Robert W. Baird lifted their price target on shares of Phreesia to $41.00 in a research report on Wednesday, December 14th. Royal Bank of Canada lifted their price target on shares of Phreesia from $22.00 to $26.00 and gave the company a “sector perform” rating in a research report on Friday, December 9th. Citigroup upgraded shares of Phreesia from a “neutral” rating to a “buy” rating and set a $40.00 price target for the company in a research report on Tuesday, December 13th. DA Davidson boosted their price objective on shares of Phreesia from $25.00 to $28.00 in a research report on Friday, December 9th. Finally, Needham & Company LLC boosted their price objective on shares of Phreesia from $35.00 to $40.00 and gave the company a “buy” rating in a research report on Wednesday, January 4th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $37.07.

Insider Activity

In other news, CFO Randy Rasmussen sold 4,765 shares of the company’s stock in a transaction dated Thursday, February 2nd. The shares were sold at an average price of $40.00, for a total transaction of $190,600.00. Following the transaction, the chief financial officer now owns 145,594 shares in the company, valued at $5,823,760. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, SVP David Linetsky sold 11,378 shares of the company’s stock in a transaction dated Thursday, February 2nd. The shares were sold at an average price of $39.55, for a total value of $449,999.90. Following the sale, the senior vice president now owns 205,489 shares in the company, valued at approximately $8,127,089.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Randy Rasmussen sold 4,765 shares of the company’s stock in a transaction dated Thursday, February 2nd. The stock was sold at an average price of $40.00, for a total transaction of $190,600.00. Following the completion of the sale, the chief financial officer now owns 145,594 shares in the company, valued at approximately $5,823,760. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 45,725 shares of company stock worth $1,707,595. Company insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of PHR. Envestnet Asset Management Inc. grew its position in shares of Phreesia by 11.7% during the 1st quarter. Envestnet Asset Management Inc. now owns 9,692 shares of the company’s stock valued at $255,000 after acquiring an additional 1,015 shares during the period. JPMorgan Chase & Co. grew its position in shares of Phreesia by 160.9% during the 1st quarter. JPMorgan Chase & Co. now owns 85,546 shares of the company’s stock valued at $2,254,000 after acquiring an additional 52,755 shares during the period. Raymond James Financial Services Advisors Inc. grew its position in shares of Phreesia by 20.7% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 8,427 shares of the company’s stock valued at $222,000 after acquiring an additional 1,447 shares during the period. Bank of New York Mellon Corp grew its position in shares of Phreesia by 0.9% during the 1st quarter. Bank of New York Mellon Corp now owns 219,598 shares of the company’s stock valued at $5,788,000 after acquiring an additional 2,047 shares during the period. Finally, PNC Financial Services Group Inc. boosted its holdings in Phreesia by 27.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 16,059 shares of the company’s stock worth $424,000 after buying an additional 3,473 shares during the period. 92.23% of the stock is owned by institutional investors.

Phreesia Company Profile

(Get Rating)

Phreesia, Inc is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products.